256 Newsroom — Uganda's Digital News Infrastructure
Business

Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment - Nature

Share
Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment - Nature
Image · Nature.com

What the report says

Six proteomic clocks are applied in a clinical trial to assess anti-aging effects.

Read the full report at Nature.com →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

Related reporting